Answers are grounded in this paper and cite their sources.
Background: Non-alcoholic fatty liver disease is the most prevalent widespread liver disease that may progress to liver fibrosis and cirrhosis.Aim: To compare the possible hepatoprotective effects of probiotics versus silymarin on a model of non-alcoholic fatty liver disease in adult male albino rats.Materials and methods: Five equal groups were created by randomly dividing fifty adult albino male rats; group I (control). Rats in the remaining groups received a high-fat, high-fructose diet daily for eight weeks, then they were divided into: groups II in which the animals were sacrificed after 8 weeks and group III in which the animals were left without treatment for a further 4 weeks, groups IV and V were given high fat high fructose diet for 8 weeks then received oral probiotics and silymarin daily (respectively) for further four weeks, then they were sacrificed. Following the experiment, liver samples were exposed to hematoxylin and eosin, Masson`s trichrome, and immunohistochemical techniques including proliferating cell nuclear antigen (PCNA) and hepatocyte-paraffin-1. Histomorphometric studies were also done.Results: A high-fat high-fructose diet resulted in liver vacuolations, a significant increase in collagen deposition, and PCNA expression, while Hepatocyte Paraffin-1 expression showed a significant decrease. Significant improvement of all histological aspects was noticed in probiotics and silymarin-treated groups. However, the silymarin-treated group showed a better effect compared to the probiotic-treated group.Conclusion: administration of both probiotics and silymarin improved Non-alcoholic fatty liver disease. However, silymarin was superior to probiotics.
No takes yet. Share an insight, caveat, or question.
Ibrahim et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: